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Fig. 2. Doppler ultrasound scan of the lesion. Left: power Doppler
image. Note the well-defined subcutaneous low echogenic mass with
blood flow, indicated by the central whitish area. Cranial bone
(arrowhead). Right: pulse Doppler image. Note the pulsatile and
arterial flow.
Topical All-trans Retinoic Acid Does not Influence Minimal Erythema Doses for UVB Light in
Normal Skin
Sir,
Retinoids are used in several skin disorders, such as acne,
psoriasis and ichthyoses. It is well established that retinoids
interfere with epidermal proliferation (1, 2), keratinization (3)
and inflammation control (4). Retinoids influence UV-induced
skin changes (5). Topical all-trans retinoic acid (RA) improves
photodamaged skin (5, 6).
Parallel with the therapeutic effect, topical retinoids often
cause irritation, with erythema and some scaling (7).
Although the irritant effect is probably not involved in the
therapeutic action of retinoids, it is possible that the irritation
property of all-trans RA could be, in part, accountable for
some therapeutic effects (1, 7).
In this study we would like to challenge the common belief
that topical retinoids enhance UV-induced inflammation. We
therefore evaluated the minimal erythema dose (MED) for
UVB irradiation on topical all-trans RA (tretinoin cream
0.05%) pre-treated skin compared with vehicle cream pre-
treated skin and untreated skin. The degree of erythema at
different times before and after UVB irradiation was scored in
the 3 different areas.
The following questions were addressed: (i) To what extent
does a 7-day treatment of normal skin with all-trans RA
0.05% in its vehicle or its vehicle alone induce erythema? (ii)
To what extent do these creams influence the MED for UV-B
irradiation? (iii) What are the dynamics of erythema 24 and
48 h after UVB irradiation in all-trans RA pre-treated skin,
vehicle pre-treated skin and untreated skin?
MATERIALS AND METHODS
The study was a single-centre, double-blind, placebo-controlled study.
Approval of the Ethics Committee was obtained. A total of 15
healthy volunteers (8 men, 7 women) participated in the study. The
mean age was 25 years (range 21 – 30 years). Their skin types were
varying from type I to type III according to Fitzpatrick’s classification
(8).
An area of 8620 cm on the ventral upper part of one leg was
treated twice daily with all-trans RA (tretinoin cream 0.05%), which is
a frequently used clinical concentration, for 10 days. An area of the
same size on the upper part of the other leg was treated with the
vehicle of tretinoin cream (per 100 g: cremor cetomacrogolis 88 g,
alcohol ketonatus 12 g and butylhydroxytolueen 40 mg) also twice
daily and for 10 days. The application of both creams on the legs was
selected at random and was applied in a double-blind manner. From
the beginning of the application, until 4 days after the last application
of the creams the volunteers were instructed to avoid sunlight
exposure and not to wash the area to which the cream was applied for
at least 1 h after each application.
On day 8 of treatment, irradiation of the skin was performed in 12
evaluable subjects in order to determine the MED with 3 series of 6
increasing intensities of UVB light related to the skin type of
the subjects: 1 series on the all-trans RA cream pre-treated skin, 1 on
the vehicle cream pre-treated skin and 1 on non-treated skin on the
lateral side of the upper part of one leg. Each dose was given to
a piece of skin of 4 cm2. For UVB irradiation, UV21 lamps were
used.
Before irradiation on days 8, 9 and 10 the skin was examined for
erythema by visual scoring. The MED was defined as the lowest UVB
dose that caused a distinct erythema with sharp margins over the
irradiated area 24 h after irradiation. For erythema the following
scale was used: 0~no erythema; 1~weak erythema; 2~moderate
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erythema; and 3~strong erythema. Visual scoring occurred under
similar conditions of light and temperature.
RESULTS AND DISCUSSIONS
Previous studies showed that erythema induced by topically
applied retinoids is frequently seen during the first weeks of
treatment and usually subsides with continued treatment. This
erythematous reaction is clinically similar to a mild irritant
dermatitis (9) and therefore is designated also as ‘retinoid
dermatitis’ (10). In this study the Wilcoxon matched-pairs
signed-ranks test showed a significant difference (pv0.01)
between all-trans RA cream and its vehicle with respect to the
induction of erythema (skin irritation) before UVB irradiation
and therefore this study reconfirms the irritative effect of all-
trans RA following twice daily applications during 7 days.
Dermatologists tend to avoid all-trans RA applications in
conjunction with UV exposure in order to avoid additive
irritation. Some studies investigated the relationship between
pre-treatment with all-trans RA and UVB irradiation,
regarding this expected additive irritation or intensity of
erythema (11, 12). However, no data are shown about the
question whether all-trans RA can influence the value of the
MED for UVB light itself.
The present study showed no significant difference
(pv0.05) as to MED values either 24 or 48 h after UVB
irradiation between the all-trans RA cream treated skin, the
vehicle cream treated skin and untreated skin (Fig.1) using the
ANOVA test. When looking at the relationship between skin
type and MED value a significant higher MED value was
found in skin type 3 vs. skin type 1 and 2 (pv0.01).
As both all-trans RA cream and the vehicle cream in itself
can induce erythema of the skin, it might be difficult to grade
post UVB irradiation erythema in retinoid-treated areas.
However, a marked difference was found in erythema pattern
between cream-induced erythema and UVB-induced ery-
thema. UVB-induced erythema showed a diffuse erythema,
while (especially all-trans RA) cream-induced erythema
showed a marked erythema restricted to the perifollicular
areas. This perifollicular pattern may be related to the actions
of all-trans RA on the pilosebaceous duct and can also be
seen with other irritants, e.g. glycolic acid (13). These 2
distinct patterns of erythema permitted us to score both
parameters independently and separately.
The present study shows that topical treatment with all-
trans RA does not influence the response to a single exposure
to UVB light and does not change the MED.
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Fig. 1. Minimal erythema doses (mean¡SEM) for UVB light at
test areas treated with all-trans retinoic acid (RA), vehicle and
untreated skin 24 and 48 hours after irradiation.
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